Literature DB >> 14027052

Some problems of hyperparathyroidism.

C E DENT.   

Abstract

Entities:  

Keywords:  HYPERPARATHYROIDISM

Mesh：

Year:  1962        PMID： 14027052      PMCID： PMC1926762          DOI： 10.1136/bmj.2.5317.1419

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  42 in total

1.  Diabetes mellitus and primary hyperparathyroidism.

Authors:  C H Walsh; N G Soler; J M Malins
Journal:  Postgrad Med J       Date:  1975-07       Impact factor: 2.401

2.  PRIMARY HYPERPARATHYROIDISM AND PSYCHOSIS.

Authors:  S AGRAS; D C OLIVEAU
Journal:  Can Med Assoc J       Date:  1964-12-26       Impact factor: 8.262

3.  HYPO-HYPERPARATHYROIDISM.

Authors:  J M COSTELLO; C E DENT
Journal:  Arch Dis Child       Date:  1963-08       Impact factor: 3.791

4.  VOCAL CORD PARALYSIS AND VOICE CHANGES IN PATIENTS WITH SURGICAL HYPOPARATHYROIDISM.

Authors:  B T SHEARMAN; J S CLUBB; F C NEALE; S POSEN
Journal:  Br Med J       Date:  1965-09-11

5.  ASSOCIATION OF HYPERURICAEMIA AND GOUT WITH HYPERPARATHYROIDISM.

Authors:  J T SCOTT; A S DIXON; E G BYWATERS
Journal:  Br Med J       Date:  1964-04-25

Review 6.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

7.  Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery.

Authors:  R Prager; G Schernthaner; B Niederle; R Roka
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

8.  Effect of posture on total phenytoin plasma concentration.

Authors:  F Abalan; G Vinçon; W Ellisson; M Sousselier; F Demotes-Mainard; E Lachiver; H Albin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Interpretation of serum calcium in patients with abnormal serum proteins.

Authors:  R B Payne; A J Little; R B Williams; J R Milner
Journal:  Br Med J       Date:  1973-12-15

10.  25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol.

Authors:  J M Gertner; M Domenech
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.